Metraipolis › archive › dc_29f45ceea8d3

Recommended long COVID outcome measures and their implications for clinical trial design, with a focus on post-exertional malaise — Europe PMC PMID:41421320

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41421320
DOI
10.1016/j.ebiom.2025.106083
License (as archived)
solo-consultazione
Archived
2026-11-07T12:42:54.502Z
SHA-256 of the archived text
782916f2420d9484f341f1388f26b3ed4bd804170fa9d2e6597c55026a7b59a3
Stable URL of this page
https://metraipolis.com/documento/dc_29f45ceea8d3

How to cite

Recommended long COVID outcome measures and their implications for clinical trial design, with a focus on post-exertional malaise — Europe PMC PMID:41421320 — Europe PMC (en), https://europepmc.org/article/MED/41421320 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_29f45ceea8d3 (Metraipolis archive dc_29f45ceea8d3, sha256 782916f2420d9484f341f1388f26b3ed4bd804170fa9d2e6597c55026a7b59a3)
BibTeX
@misc{dc29f45ceea8d3,
  title = {Recommended long COVID outcome measures and their implications for clinical trial design, with a focus on post-exertional malaise — Europe PMC PMID:41421320},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41421320},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_29f45ceea8d3; sha256 782916f2420d9484f341f1388f26b3ed4bd804170fa9d2e6597c55026a7b59a3},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41421320. Agents can read the archived copy with the MCP tool read_document.